These results suggested that TR1419 CAR-T cells exhibited cell killing efficacy not only by inducing T cell–mediated cytolysis of tumor cells but also by promoting tumor cell death through activation of the TRAIL-R1–dependent apoptotic pathway. Here, TNFRSF10A is linked to neoplasm.